Vaginal atrophy is the thinning, drying, and loss of elasticity in the vaginal walls that happens when your body produces less estrogen. It affects roughly 40 to 50 percent of postmenopausal women, though it can begin years before menopause ends. Since 2014, the condition has been grouped under a broader term, genitourinary syndrome of menopause (GSM), which reflects the fact that it affects not just the vagina but also the vulva, urethra, and bladder.
Unlike hot flashes, which tend to fade over time, vaginal atrophy is progressive. Without treatment, the tissue changes continue and symptoms typically worsen with age.
What Happens Inside the Tissue
Estrogen keeps the vaginal lining thick, moist, and flexible. It drives the growth of the surface cell layers, stimulates blood flow, and helps maintain the collagen and elastin fibers that give the tissue its stretch and resilience. When estrogen drops, all of these processes slow down.
The vaginal lining, which normally consists of multiple cell layers with natural moisture, becomes significantly thinner. The small folds (rugae) that allow the vagina to expand flatten out. Collagen fibers shift in composition and the tissue becomes stiffer, less able to bounce back from stretching or minor injury. Blood supply decreases, which reduces the natural lubrication that the vaginal walls produce. The tissue also becomes more fragile and more prone to small tears, irritation, and inflammation.
Another less obvious change involves pH. A healthy premenopausal vagina sits at a mildly acidic pH of around 3.5 to 4.5, which helps keep harmful bacteria in check. After menopause, vaginal pH rises into the 5.0 to 7.5 range, making infections more likely.
Who Gets It and Why
Natural menopause is the most common cause, but anything that lowers estrogen can trigger vaginal atrophy, sometimes decades earlier than expected. One large study found that prevalence ranged from about 19 percent in women aged 40 to 45 up to nearly 54 percent in women aged 52 to 55. Postmenopausal women were more than three times as likely to have it compared to premenopausal women of the same age.
Beyond natural menopause, common triggers include:
- Surgical menopause. Removal of both ovaries, whether for cancer treatment or as a preventive measure in women carrying BRCA gene mutations, causes an immediate and sharp estrogen drop.
- Cancer treatments. Chemotherapy drugs can destroy ovarian follicles, leading to premature ovarian failure. Pelvic radiation not only damages the ovaries but also disrupts the blood supply and nerve function in vaginal tissue itself, causing scarring and fibrosis.
- Hormone-blocking medications. Drugs used to treat hormone-sensitive breast cancer, such as aromatase inhibitors and tamoxifen, deliberately suppress estrogen activity throughout the body.
- Breastfeeding. Estrogen levels drop during lactation, and some women experience noticeable vaginal dryness and discomfort during this period, though it typically resolves after weaning.
Common Symptoms
The hallmark symptoms are vaginal dryness, burning, and discomfort during sex. Many women describe a persistent feeling of irritation or soreness, sometimes accompanied by light spotting after intercourse due to the fragile tissue tearing easily.
Because the same estrogen-sensitive tissue extends to the urethra and bladder lining, urinary symptoms are common too. These include a frequent urge to urinate, a burning sensation during urination, and an increased rate of urinary tract infections. Some women also notice changes in discharge or a feeling of vaginal tightness or shortening.
Many women don’t connect these symptoms to menopause, or feel uncomfortable bringing them up. Studies consistently show that the condition is underreported and undertreated, even though effective options exist.
Over-the-Counter Options
For mild symptoms, non-prescription products can provide meaningful relief. The two main categories work differently and serve different purposes.
Vaginal moisturizers are designed for regular use, typically one to three times per week. They adhere to the vaginal lining and draw water into the tissue, improving hydration, elasticity, and pliability over time. Think of them like a facial moisturizer for the vaginal walls. They work best when used consistently, not just when symptoms flare.
Lubricants, by contrast, are meant for use during sexual activity. They come in water-based, silicone-based, or oil-based formulas and reduce friction on fragile tissue. They provide immediate but temporary relief. Lubricants don’t change the underlying tissue, so they work best as a complement to a moisturizer rather than a replacement for one.
Prescription Treatments
When moisturizers and lubricants aren’t enough, local estrogen therapy is the most widely used prescription approach. It delivers a small dose of estrogen directly to the vaginal tissue, which reverses many of the cellular changes: the lining thickens, moisture returns, elasticity improves, and pH drops back toward a healthier range. Very little estrogen enters the bloodstream with local delivery, which makes it suitable for many women who can’t or prefer not to take systemic hormone therapy.
Local estrogen comes in several forms:
- Vaginal cream is typically applied daily for the first one to three weeks, then reduced to one to three times per week.
- Vaginal tablets or suppositories are inserted daily for two weeks, then twice weekly for ongoing maintenance.
- Vaginal ring is a soft, flexible ring placed in the upper vagina that releases a steady dose of estrogen for about three months before being replaced.
For women who prefer not to use estrogen at all, there are two main alternatives. One is an oral medication called ospemifene, which acts like estrogen specifically in vaginal tissue while blocking estrogen activity in other parts of the body. Clinical trials showed it significantly increased the thickness and maturity of vaginal lining cells, lowered vaginal pH, and reduced pain during sex compared to placebo. The other option is a vaginal insert containing DHEA, a hormone precursor that the vaginal tissue converts locally into small amounts of estrogen and testosterone.
The Role of Sexual Activity
Regular sexual activity, whether with a partner or through self-stimulation, appears to have a protective effect on vaginal tissue. A study of 52 postmenopausal women found that those who were sexually active (three or more times per month) had measurably less vaginal atrophy across six different physical dimensions compared to women who were sexually inactive. The sexually active women also had higher circulating levels of androgens, hormones that play a role in maintaining tissue health and sexual interest.
The likely mechanism is straightforward: arousal increases blood flow to the vaginal walls, which supports tissue health and natural lubrication. This doesn’t mean sexual activity alone can prevent atrophy, but it may slow progression and complement other treatments. For women who experience pain during intercourse because of atrophy, treating the underlying tissue changes first with moisturizers or estrogen therapy can make resuming sexual activity more comfortable.